期刊文献+

65例广西籍冠心病患者胱硫醚β-合酶基因9208G>A突变频率

暂未订购
导出
摘要 目的探讨胱硫醚β-合酶(CBS)基因9208G>A突变在广西籍冠心病(CHD)发病中的意义。方法采用等位基因特异性扩增(ASA)技术对65例广西籍冠心病患者(CHD组)和65例健康者(对照组)进行CBS9208G>A的检测。结果CHD组的CBS基因A/A,A/G和G/G型突变频率分别为9·32%,29·23%和61·54%,对照组分别为3·08%,15·38%和81·54%。CHD组A等位基因频率为23·8%,G等位基因频率为76·15%,对照组分别为10·76%和89·23%,两组间基因型以及A等位基因频率分布差异均有显著性(P<0·05)。结论CBS9208G>A突变与广西籍CHD有重要相关性。
出处 《广东医学》 CAS CSCD 北大核心 2008年第6期954-955,共2页 Guangdong Medical Journal
基金 广西教育厅立项项目(编号:200610LX056) 广西中医学院重点项目(编号:院自JD2004002)
  • 相关文献

参考文献9

  • 1MILES E W, KRAUS J P. Cystathionine beta - synthase:structure, function, regulation, and location of homocystinuriacausing mutations[J]. J Biol Chem, 2004, 279(29) : 29 871 -29 874.
  • 2刘方清 张晨.胱硫醚β-合酶基因多态性与颈动脉粥样硬化的相关性.中国实用医药,2007,2(27):1-4.
  • 3LIAO D, TAN H, HUI R. Hyperhomocysteinemia decreases circulating high - density lipoprotein by inhibiting apolipoprotein a - Ⅰ protein synthesis and enhancing HDL cholesterol clearance [ J ]. Circ Res, 2006, 99(6) : 565 -565.
  • 4ROBERT K, CHASEE J F, SANTIARD BARON D. Altered gene expression in liver from a murine model of hyperhomocysteinemia [J]. Biol Chem, 2003, 278(34) : 31 504 -31 511.
  • 5CHANDRA G, PAL S, GANGADHYAY P K. Cystathionine beta -synthase T833C/844ins68 polymorphism and stroke[ J]. Neurol India, 2006, 54(4) : 446 -446.
  • 6GALLAGHER P M, WARD P, TAN S, et al. High frequency (71%) of cystathionine β- synthase mutation G307S in Irish homocystinuria patients[J]. Hum Mutation, 1995, 6(2) : 177 - 180.
  • 7ATSUSUHIMA F K, OLIVERIUSOVA J, SAKAMOTO O, et al. Expression study of mutant cystathionine β- synthase found in Japanese patients with homocystinuria[ J]. Molecular Genetics and Metabolism, 2006, 87(4) : 323 -328.
  • 8陈欣,刘克强,穆红.胱硫醚-β-合酶(CBS)基因与冠心病发病机制的研究[J].天津医药,2003,31(3):158-160. 被引量:12
  • 9许海燕,贾云香,陈在嘉,刘海波,刘晓宁,惠汝太.冠心病患者亚甲基四氢叶酸还原酶A1298C和胱硫醚缩合酶G919A基因多态性的研究[J].辽宁医学杂志,2007,21(2):57-58. 被引量:6

二级参考文献11

  • 1邵燕,章成国,崔金环.血浆同型半胱氨酸及胱硫醚β合成酶多态性与脑血栓形成[J].第一军医大学学报,2005,25(3):351-353. 被引量:6
  • 2Bailey LB, Gregory JF.Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance,risk and impact an folate requirement. J Nutr, 1999, 129(5):919~22.
  • 3Rudsum- Hilleland PM.Recent date are not in conflict with homocysteine as a cardiovascular risk factor. Cur Opin Lipidol,1998,9(6): 533~ 9.
  • 4Tsai MY, Garg U, Key NS, et al. Molecular and biochemical approaches in the identification of heterozygous for homocysteinuria. Atherosclerosis, 1996, 122: 69~77.
  • 5Tsai MY,Welge BG, Hanson NQ, et al. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis, 1999, 143(1): 163~70.
  • 6PePe G, Vanegas OC, Rickards O, et al. World distribution of the T 833 C/844 INS 68 CBS in cis double mutation:a reliable anthropological marker. Hum Genet, 1999, 104(2): 126~9.
  • 7Kozich V, Karus E, de Franchis R, et al. Hyperhomocysteinemia in premature arterial disease: examination of cystathionine- β - synthase alleles at the molecular level. Hum Mol Genet, 1995,4(4) :623~9.
  • 8Kluijtmans LA, van den Heuvel LP, Boers GH, et al. Molecular genetic analysis in mild Hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet, 1996, 58( 1 ): 35~ 9.
  • 9Hanson NQ,Aras O,Yang F.C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene:incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.Clin Chem,2001,47(4):661
  • 10高炜,姜宁,朱国英,孟昭亨,汤键.冠心病患者血浆同型半胱氨酸的变化及其机制的探讨[J].中华医学杂志,1998,78(11):821-823. 被引量:52

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部